证券代码：600085 证券简称：同仁堂 公告编号：2025-014 2 张朝华女士因调任本公司控股股东中国北京同仁堂（集团）有限责任公司副总经理， 辞去本公司总经理职务。 北京同仁堂股份有限公司（以下简称公司）于 2025 年 6 月 4 日召开第十届 董事会第十次会议，审议通过《关于选举公司第十届董事会非独立董事的预案》 《关于聘任公司高级管理人员的议案》，现将有关事项公告如下： 一、董事、高级管理人员离任情况 | | | | | | | 是否继续 | | 是否存在 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 姓 | 名 | 离任职务 | 离任时间 | 原定任期 | 离任 | 在公司及 | 具体职务 | 未履行完 | | | | | | 到期日 | 原因 | 控股子公 | | 毕的公开 | | | | | | | | 司任职 | | 承诺 | | 张朝华 | | 总经理 | 2025/6/4 | 2027/6/13 | 工作 | 是 | 公司董事、董事 会法治建设委 | 否 | | | | | | | 调整 | | 员会主任委员 ...

证券代码：600085 证券简称：同仁堂 公告编号：2025-013 北京同仁堂股份有限公司 二、会议审议情况 (一) 审议通过了《关于选举公司第十届董事会非独立董事的预案》 同意选举陈加富先生（简历附后）为公司第十届董事会非独立董事，任期自 公司股东大会审议通过之日起至第十届董事会任期届满之日止。 表决结果：同意 9 票，反对 0 票，弃权 0 票。 本事项已经公司第十届董事会提名委员会 2025 年第一次会议审核通过，尚 需提交公司股东大会审议，关于召开股东大会的信息将另行公告。 (二) 审议通过了《关于聘任公司高级管理人员的议案》 第十届董事会第十次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、会议召开情况 北京同仁堂股份有限公司（以下简称公司）第十届董事会第十次会议于 2025 年 6 月 4 日在公司会议室以现场结合通讯会议方式召开。本次会议通知已提前送 达全体董事，与会各位董事均已知悉与本次会议所议事项的相关必要信息。本次 董事会会议应出席董事 9 人，实际出席 9 人。公司全体监事及部分高级管 ...

同仁堂科技在港交所公告，邸淑兵辞任公司董事长，陈加富辞任总经理 ...

智通财经APP讯，同仁堂科技(01666)发布公告，于2025年6月4日，北京同仁堂科技发展股份有限公司 (本公司，及其附属公司，本集团)董事会接到邸淑兵先生(邸先生)、陈加富先生(陈先生)及冯智梅女士 (冯女士)各自的辞任函，告知董事会邸先生由于工作变动原因申请辞任本公司董事、董事长、董事会辖 下的提名委员会(提名委员会)主席及战略与规划委员会(战略与规划委员会)主席及香港联合交易所(香港 联交所)有限公司证券上市规则第3.05条项下的本公司授权代表(授权代表);陈先生由于工作变动原因申 请辞任本公司董事、战略与规划委员会委员及本公司总经理(总经理);及冯女士由于工作变动原因申请辞 任本公司董事及本公司副总经理。 上述邸先生辞任本公司董事长、提名委员会主席及战略与规划委员会主席及授权代表，陈先生辞任总经 理及冯女士辞任本公司副总经理均已自2025年6月4日起生效。 董事会于2025年6月4日决议： (i)非执行董事张毅先生已调任为执行董事，其任期自2025年6月4日起至 本届董事会任期结束终止，并在其任期届满时可以连选连任。董事会建议提请股东大会批准张毅先生担 任本公司执行董事的薪酬为零，张毅先生将依据其在 ...

Group 1 - The company, Tongrentang Technology, has successfully cultivated organic raspberries in its Zhejiang planting base, which began production in late May [1] - The organic certification process requires a rigorous 1-2 year audit, ensuring no use of genetically modified organisms or synthetic chemicals [4][3] - The company has established a complete traceability system for its organic products, documenting all agricultural activities from seed sourcing to harvesting [6] Group 2 - The Zhejiang planting base has adopted a semi-wild and ecological planting method, achieving organic conversion certification by May 2024 [6] - The company emphasizes the importance of maintaining organic standards and has already obtained organic conversion certification for nine medicinal herbs [8] - The commitment to organic certification reflects the company's dedication to quality and consumer trust, aligning with its quality standards [8]

Core Viewpoint - The collaboration between Yili, Fosun Health, and Tongrentang marks a new phase in building a comprehensive health ecosystem that integrates prevention, treatment, and rehabilitation [1][2]. Group 1: Strategic Collaboration - The event in Foshan signifies the strategic partnership aimed at enhancing health services through collaboration among government, enterprises, and medical institutions [1]. - Yili's Vice President, Li Xue, emphasized the need for diverse and refined health services in line with the "Healthy China 2030" strategy, combining quality nutrition products with professional medical services [1]. - Fosun Health's CEO, Hu Hang, highlighted the innovative "medical + nutrition" model that supports local hospitals and expands health management applications [1]. Group 2: Product Launch - The launch introduced several new products, including: - Xinhua Shugang Formula Milk Powder (blood sugar management) - Xinhua Bone Energy Formula Milk Powder (bone care) - Xinhua Evening Formula Milk Powder (sleep improvement) - Xinhua Heart Vitality Formula Milk Powder (cardiovascular health) - Qingmu Red Ginseng Revitalizing Milk Powder (blood and energy regulation) [1]. Group 3: Future Plans - Yili plans to deepen resource integration with Fosun Health and Tongrentang, promoting the "medical + nutrition" model nationwide [2]. - The initiative aims to create a more comprehensive health service network that combines traditional Chinese medicine with modern nutritional science [2].

Core Viewpoint - The event organized by Beijing Daily aimed to enhance health awareness among the elderly and provide summer health tips through a collaboration with Beijing Tongrentang Traditional Chinese Medicine Hospital [1][7]. Group 1: Event Overview - The event took place on May 20, focusing on summer health issues for the elderly, featuring health knowledge dissemination and free medical consultations [1][7]. - Participants received a "Health Service Manual 2025" with over 200 copies distributed, providing practical health information and resources [8]. Group 2: Health Recommendations - Medical professionals emphasized three key areas for summer health: preventing damp heat, strengthening the spleen and stomach, and protecting yang energy [3]. - Specific dietary recommendations included seasonal fruits and vegetables like cucumber and winter melon, and suggested meals such as winter melon and barley duck soup [4]. Group 3: Interactive and Consultation Services - The event included an interactive segment where participants learned about traditional health practices, such as "拍八虚" for promoting overall well-being [6]. - Health consultation areas were set up for personalized advice, basic health checks, and medication guidance, addressing individual health concerns [6]. Group 4: Future Initiatives - The hospital plans to continue public welfare activities to meet the health needs of the elderly and promote traditional Chinese medicine [7].

Core Viewpoint - The 17th Ditan Traditional Chinese Medicine Health Culture Festival was successfully held in Beijing, showcasing the integration of traditional culture and health through various TCM products and practices [1]. Company Overview - Tongrentang Technology Development Co., Ltd. showcased a wide range of health products, emphasizing its strength in the health industry and innovative capabilities [3][5]. - The company has developed a product matrix in the health sector, including six major categories: health foods, health drinks, deer products, cosmetics, fragrance products, and disinfection products [3]. Product Highlights - The festival featured dozens of representative products from the "big health" matrix, demonstrating the company's rich heritage in TCM culture and product development [5]. - The traditional production technique of Ejiao cake was demonstrated live, highlighting the craftsmanship and time-intensive process involved [7]. - The company has developed nearly 200 fragrance products based on classic TCM formulas, integrating traditional medicine with modern fragrance techniques [9][11]. - The cosmetics division focuses on the research and application of traditional plants, with products like ginseng vitamin E lotion gaining popularity among consumers [13]. Cultural Impact - The festival allowed the public to deeply experience the charm of TCM culture and health services, promoting the benefits of TCM to a wider audience [15].

Policy Developments - The National Medical Products Administration (NMPA) has announced the implementation of the "Quality Management Standards for Online Sales of Medical Devices," effective from October 1, 2025. Regulatory authorities are required to guide online sellers and e-commerce platforms in conducting internal training and assessments related to quality management systems, product information display, and risk monitoring [2]. Drug and Device Approvals - BeiGene announced positive results from the Phase 2 clinical trial (DeLLphi-307) of tarlatamab for treating extensive-stage small cell lung cancer (ES-SCLC) patients in China, with detailed data to be presented at an upcoming medical conference [4]. Capital Market Activities - Shanghai BoYin Biotechnology Co., Ltd. has completed a multi-million angel round financing, led by Zhangjiang Life and Health Industry Incubation Angel Fund, with funds aimed at advancing the company's product pipeline and early clinical validation of its first product [7]. Industry Developments - Yuheng Pharmaceutical has signed a co-promotion agreement with Xinghe Pharmaceutical for Pemafibrate, a novel selective PPARα modulator, which will take effect on June 1, 2025. This agreement is expected to enhance Yuheng's product pipeline and potential profit growth, although it will face competition from established products [9]. Shareholder Activities - Chengdu XianDao announced that shareholder Anji Dongfang Jiayu Enterprise Management Partnership reduced its stake by 1 million shares, decreasing its ownership from 6.2% to 5.95% [12]. - BioVeda China RMB Investment Limited plans to reduce its stake in AoJing Medical by up to 135,550 shares, having already reduced its holdings by 34,510 shares, representing 0.25% of the total shares [13].

Group 1: Product License Announcement - Beijing Tongrentang Co., Ltd. has received a Class III product license from Health Canada for its product Suhexiang Wan, allowing for potential sales in Canada [1][2] - The total research and development investment for the product by Tongrentang Pharmaceutical Factory amounts to approximately 3.05 million yuan (about 0.46 million USD) as of the announcement date [1] Group 2: Impact on Company Operations - The approval of the product license is a significant step towards market entry, but further administrative approvals, including Canadian production quality system certification, are required, which may introduce uncertainties [2] - The recent approval is not expected to have a major impact on the company's short-term operating performance [2] Group 3: Annual Shareholders Meeting Notification - The 2024 Annual Shareholders Meeting is scheduled for June 16, 2025, and will utilize a combination of on-site and online voting methods [5][6] - The meeting will take place at the company's headquarters in Beijing, with specific voting times outlined for both on-site and online participants [6][10] Group 4: Voting Procedures and Participation - Shareholders can vote through the Shanghai Stock Exchange's online voting system, with detailed instructions provided for participation [10][11] - The company aims to facilitate participation from minority investors by sending reminders and information about the meeting and voting procedures [10]